Skip to contentHelp us improve by providing feedback or contacting help@jisc.ac.uk
  • Browse
  • Publish
Sign in with ORCID

multidrug resistance

Research Topic

Language: English

Sign in for more actions

This is a research topic created to provide authors with a place to attach new problem publications.

Research topics above this in the hierarchy

  • antibiotic resistant

Research problems linked to this topic

  • Infections caused by multidrug resistant Klebsiella pneumoniae have been increasingly reported in many parts of the world.
  • Multidrug resistance (MDR) occurs in prostate cancer, and this happens when the cancer cells resist chemotherapeutic drugs by pumping them out of the cells.
  • Multidrug resistance (MDR) remains a major obstacle in cancer chemotherapy.
  • Surgical environment can play as a source of multidrug-resistance organism, what can pose as a big threat to the patients and health care professionals.
  • Clinically available medications face several hurdles that limit their therapeutic activity, including restricted access to the target tissues due to biological barriers, low bioavailability, and poor pharmacokinetic properties.
  • Multidrug-resistant tuberculosis (MDR-TB) is a growing global health threat that often requires presumptive treatment in the absence of drug susceptibility testing (DST) results.

Octopus

Contact us: help@jisc.ac.uk

Browse

Publish

About

FAQs

Get involved

Terms

Privacy

Accessibility

Cookie Policy

In partnership with

Jisc Logo

With support from

UKRI

A collaboration with

Jisc Logo